Literature DB >> 23119799

A prospective randomised study to assess the efficacy of differenct medications for relief of post-operative nasal obstruction.

A Kalan1, G S Kenyon, N Pelekoudas.   

Abstract

Surgery to the nasal septum and to the turbinates constitutes a significant part of the workload of an otolaryngologist. The patient invariably experiences short-term nasal obstruction following such surgery and different medications are commonly used to relieve this and to promote a sense of airway patency. However the efficacy of topical and systemic medication, given in the post-operative period is hot well documented. A prospective randomized trial was therefore undertaken to compare the efficacy of a topically applied vasoconstrictor and an anticholinergic agent in reducing the sensation of airway obstruction in the first week following simple nasal airway surgery. 0.5% Ephedrine hydrochloride nasal drops, Pseudoephedrine tablets and a combination of the two were compared to a control group who received no treatment. Eighty patients were randomised into four groups and nasal patency assessed by patients using a visual analogue sacle (VAS). When compared to the control group both medications were effective in relieving nasal congestion but a combination of topical and systemic therapy, given together, was superior to either agent used alone. The results achieved were independent of the seniority of the surgeon undertaking the operation.

Entities:  

Keywords:  drug therapy; nose; surgery

Year:  2001        PMID: 23119799      PMCID: PMC3450658          DOI: 10.1007/BF03028556

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  2 in total

1.  Submucous resection for deviated nasal septum: a critical appraisal.

Authors:  W K Low; D J Willatt
Journal:  Singapore Med J       Date:  1992-12       Impact factor: 1.858

2.  A prospective randomized study to assess the efficacy of post-operative nasal medication after endonasal surgery.

Authors:  P D Spraggs; M Macnamara; T Joseph
Journal:  J Laryngol Otol       Date:  1995-07       Impact factor: 1.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.